Kura Oncology (KURA) Operating Income (2010 - 2026)
Kura Oncology's (KURA) quarterly Operating Income came in at -$78.8 million in Q1 2026, down 21.82% year-on-year from -$100.8 million in Q1 2025, and down 21.82% on a QoQ basis from -$64.7 million in Q1 2025.
Kura Oncology (KURA) Operating Income (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 7 years of Operating Income data on file, last reported at -$78.8 million in Q1 2026.
- On a quarterly basis, Operating Income fell 21.82% year-over-year to -$78.8 million in Q1 2026; TTM through Mar 2026 was -$143.5 million, a 121.77% decrease from a year earlier, with the FY2025 full-year figure at -$303.6 million, down 57.16% from the prior year.
- Operating Income for Q1 2026 stood at -$78.8 million, down from -$64.7 million in the prior quarter.
- Over the last five years, Operating Income for KURA reached as high as -$64.7 million in Q1 2025 and fell as low as -$78.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Kura Oncology | 928.19 Mn | 928.19 Mn | 18.00 Mn | -78.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.82 Mn |
| Mar 31, 2025 | -64.70 Mn |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,764.00 |
| Jun 30, 2014 | -5,242.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,716.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,728.00 |
| Jun 30, 2012 | -4,996.00 |
| Mar 31, 2012 | -4,241.00 |
| Dec 31, 2011 | -7,976.00 |
| Sep 30, 2011 | -5,360.00 |
| Jun 30, 2011 | -5,837.00 |
| Mar 31, 2011 | -4,266.00 |
| Dec 31, 2010 | -7,214.00 |
| Sep 30, 2010 | -4,238.00 |